Its use is limited to people who have been diagnosed with one of three specific rare genetic disorders caused by proopiomelanocortin (POMC), proprotein convertase subtilisin/kexin type 1 (PCSK1), or leptin receptor (LEPR) deficiency. Here, PCSK1 is linked to hereditary disease.